戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  KSbcl-2, from human herpesvirus 8 (HHV8) or Kaposi sarcoma-associated herpesvirus.
2 uch as HIV, Epstein-Barr virus, malaria, and Kaposi sarcoma-associated herpesvirus.
3 plasm of lymphatic endothelium infected with Kaposi sarcoma-associated herpesvirus.
4         Little evidence suggests a link with Kaposi sarcoma-associated herpesvirus.
5 -like inhibitory protein (FLIP) protein from Kaposi sarcoma-associated herpesvirus activates the NF-k
6  hundred percent of PELs carry the genome of Kaposi sarcoma-associated herpesvirus and a majority are
7    The oncogenic gamma-herpesviruses EBV and Kaposi sarcoma-associated herpesvirus are ubiquitous hum
8 an gammaherpesviruses Epstein-Barr virus and Kaposi Sarcoma-associated herpesvirus both contain a gly
9 avity-based lymphoma cells were positive for Kaposi sarcoma-associated herpesvirus by PCR and were ne
10                                              Kaposi sarcoma-associated herpesvirus-encoded interleuki
11                                              Kaposi sarcoma-associated herpesvirus encodes viral IL-6
12                                              Kaposi sarcoma-associated herpesvirus GPCR (kGPCR) activ
13 alysis of lymphoma DNA showed high levels of Kaposi sarcoma-associated herpesvirus (> 40 to 80 genome
14 other viruses such as Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus have led to the ge
15 their use as models for human infection with Kaposi sarcoma-associated herpesvirus (human herpesvirus
16  This family includes Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus, human pathogens a
17                          Effects of Ca-SP on Kaposi sarcoma-associated herpesvirus/human herpes virus
18                Ca-SP also inhibited entry of Kaposi sarcoma-associated herpesvirus/human herpes virus
19                                              Kaposi sarcoma-associated herpesvirus/human herpesvirus
20                                  The role of Kaposi sarcoma-associated herpesvirus in the development
21 ly that the open reading frame 45 (ORF45) of Kaposi sarcoma-associated herpesvirus interacts with p90
22 sion of the viral interleukin-6 homolog from Kaposi sarcoma-associated herpesvirus is also sufficient
23                                              Kaposi sarcoma-associated herpesvirus is the causative a
24 interleukin-6 (vIL-6), a virokine encoded by Kaposi sarcoma- associated herpesvirus, is an issue of c
25           Human herpesvirus 8, also known as Kaposi sarcoma-associated herpesvirus, is etiologically
26                                We found that Kaposi sarcoma-associated herpesvirus K12-1 miRNA (23 ba
27                            Recently a virus, Kaposi sarcoma associated herpesvirus (KSHV) or human he
28 n 6 (IL-6) is an important growth factor for Kaposi sarcoma- associated herpesvirus (KSHV)-associated
29                            The genome of the Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) was
30  invariably associated with infection by the Kaposi sarcoma-associated herpesvirus (KSHV or HHV8).
31 que rhadinovirus (RRV) is closely related to Kaposi sarcoma-associated herpesvirus (KSHV) and is asso
32     Kaposi sarcoma is caused by infection of Kaposi sarcoma-associated herpesvirus (KSHV) and is char
33 A-binding domains (DBDs), LANA homologs from Kaposi sarcoma-associated herpesvirus (KSHV) and MHV68 e
34 ion that is transferable to MHV68.IMPORTANCE Kaposi sarcoma-associated herpesvirus (KSHV) and murine
35 s subfamily of gammaherpesviruses, including Kaposi sarcoma-associated herpesvirus (KSHV) and murine
36     In Sub-Saharan Africa, where HIV and the Kaposi sarcoma-associated herpesvirus (KSHV) are endemic
37                                              Kaposi sarcoma-associated herpesvirus (KSHV) can establi
38             Open reading frame 45 (ORF45) of Kaposi sarcoma-associated herpesvirus (KSHV) causes sust
39 T-cell immunity is important for controlling Kaposi sarcoma-associated herpesvirus (KSHV) diseases su
40                          Among 233 children, Kaposi sarcoma-associated herpesvirus (KSHV) DNA was det
41                                              Kaposi sarcoma-associated herpesvirus (KSHV) encodes 12
42                               The K1 gene of Kaposi sarcoma-associated herpesvirus (KSHV) encodes a t
43 n tumor viruses Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) establish p
44 nces were all approximately equidistant from Kaposi sarcoma-associated herpesvirus (KSHV) gB sequence
45                                              Kaposi sarcoma-associated herpesvirus (KSHV) has a causa
46                                              Kaposi sarcoma-associated herpesvirus (KSHV) has been as
47                                              Kaposi sarcoma-associated herpesvirus (KSHV) has been id
48                                          The Kaposi sarcoma-associated herpesvirus (KSHV) has been li
49 , a multifunctional protein expressed by the Kaposi sarcoma-associated herpesvirus (KSHV) in latently
50                                              Kaposi sarcoma-associated herpesvirus (KSHV) infection i
51                                              Kaposi sarcoma-associated herpesvirus (KSHV) infection i
52                   The cellular reservoir for Kaposi sarcoma-associated herpesvirus (KSHV) infection i
53 me studies have inferred that an epidemic of Kaposi sarcoma-associated herpesvirus (KSHV) infection i
54                          Recent reports link Kaposi sarcoma-associated herpesvirus (KSHV) infection o
55                To develop an animal model of Kaposi sarcoma-associated herpesvirus (KSHV) infection u
56 e of the JCI, Ganem and colleagues show that Kaposi sarcoma-associated herpesvirus (KSHV) inhibits CD
57                                              Kaposi sarcoma-associated herpesvirus (KSHV) is a B-lymp
58                                              Kaposi sarcoma-associated herpesvirus (KSHV) is a human
59                                              Kaposi sarcoma-associated herpesvirus (KSHV) is a human
60                                              Kaposi sarcoma-associated herpesvirus (KSHV) is a member
61 ically, the thymidine kinase (TK) encoded by Kaposi sarcoma-associated herpesvirus (KSHV) is an extre
62                                              Kaposi sarcoma-associated herpesvirus (KSHV) is an oncog
63                                              Kaposi sarcoma-associated herpesvirus (KSHV) is an oncog
64                                              Kaposi sarcoma-associated herpesvirus (KSHV) is associat
65                                              Kaposi sarcoma-associated herpesvirus (KSHV) is associat
66                                              Kaposi sarcoma-associated herpesvirus (KSHV) is consiste
67                                              Kaposi sarcoma-associated herpesvirus (KSHV) is etiologi
68                                              Kaposi sarcoma-associated herpesvirus (KSHV) is involved
69                                              Kaposi sarcoma-associated herpesvirus (KSHV) is known to
70                  Human herpesvirus 8 (HHV-8)/Kaposi sarcoma-associated herpesvirus (KSHV) is linked t
71                                              Kaposi sarcoma-associated herpesvirus (KSHV) is linked w
72                               Infection with Kaposi sarcoma-associated herpesvirus (KSHV) is now know
73                To assess the role of IL-6 in Kaposi sarcoma-associated herpesvirus (KSHV) latency, KS
74                                          The Kaposi sarcoma-associated herpesvirus (KSHV) latency-ass
75 ng of genes believed to be essential for the Kaposi sarcoma-associated herpesvirus (KSHV) latent life
76  newly recognized gamma herpesvirus known as Kaposi sarcoma-associated herpesvirus (KSHV) or human he
77                                              Kaposi sarcoma-associated herpesvirus (KSHV) ORF57 is a
78                                              Kaposi sarcoma-associated herpesvirus (KSHV) ORF57 is a
79           There is substantial evidence that Kaposi sarcoma-associated herpesvirus (KSHV) plays an im
80 show that the lytic replication cycle of the Kaposi sarcoma-associated herpesvirus (KSHV) promotes do
81                                              Kaposi sarcoma-associated herpesvirus (KSHV) stimulates
82   In a previous study, it was shown that the Kaposi sarcoma-associated herpesvirus (KSHV) was specifi
83 at treatment of cells latently infected with Kaposi sarcoma-associated herpesvirus (KSHV) with glycyr
84                                              Kaposi sarcoma-associated herpesvirus (KSHV), also known
85                                              Kaposi sarcoma-associated herpesvirus (KSHV), also known
86  associated with epigenetic modifications of Kaposi sarcoma-associated herpesvirus (KSHV), an oncogen
87                Gammaherpesviruses, including Kaposi sarcoma-associated herpesvirus (KSHV), establish
88                      Many viruses, including Kaposi sarcoma-associated herpesvirus (KSHV), have evolv
89                                              Kaposi sarcoma-associated herpesvirus (KSHV), or human h
90                 Cellular immune responses to Kaposi sarcoma-associated herpesvirus (KSHV), the etiolo
91 virus (HIV) type 1-infected subjects without Kaposi sarcoma-associated herpesvirus (KSHV)-associated
92                                          The Kaposi sarcoma-associated herpesvirus (KSHV)-encoded lat
93      We recently identified polymorphisms in Kaposi sarcoma-associated herpesvirus (KSHV)-encoded mic
94                                    Moreover, Kaposi sarcoma-associated herpesvirus (KSHV)-encoded vir
95           We report that A20 is expressed in Kaposi sarcoma-associated herpesvirus (KSHV)-infected pr
96                               All PELs carry Kaposi sarcoma-associated herpesvirus (KSHV).
97 a and like Kaposi sarcoma has been linked to Kaposi sarcoma-associated herpesvirus (KSHV).
98 as found to be very similar to that of human Kaposi sarcoma-associated herpesvirus (KSHV).
99                        The seroprevalence of Kaposi sarcoma-associated herpesvirus (KSHV)/human herpe
100                                              Kaposi sarcoma-associated herpesvirus (KSHV)/human herpe
101                                              Kaposi sarcoma-associated herpesvirus (KSHV; also known
102                                          The Kaposi sarcoma-associated herpesvirus (KSHV; or human he
103                                              Kaposi-sarcoma-associated herpesvirus (KSHV or HHV8) has
104 ) to infection by a novel human herpesvirus (Kaposi sarcoma-associated herpesvirus [KSHV]) is one of
105 tiated blood vascular endothelial cells with Kaposi sarcoma-associated herpesvirus leads to their lym
106 o the sustained activation of ERK and RSK in Kaposi sarcoma-associated herpesvirus lytic replication.
107                                              Kaposi sarcoma-associated herpesvirus may be involved in
108 lity complex class I in cells expressing the Kaposi sarcoma-associated herpesvirus protein K3, is una
109 n gamma-2 herpesvirus closely related to the Kaposi sarcoma-associated herpesvirus, replicates lytica
110                  Human herpesvirus 8 (HHV-8; Kaposi sarcoma-associated herpesvirus)-specific cytotoxi
111 and endothelial cells latently infected with Kaposi sarcoma-associated herpesvirus, suggesting that a
112 V4), cytomegalovirus (HHV5), HHV6, HHV7, and Kaposi sarcoma-associated herpesvirus (termed KSV or HHV
113                                              Kaposi sarcoma-associated herpesvirus vIRF is a viral tr

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top